Nojin Biological Products Portfolio
Scientific monographs, clinical data, and specifications of human plasma-derived biopharmaceuticals.

Human Albumin ALBUJINE 20%
Human Albumin 20% - Solution Vial 50 ml
Nojin Human Albumin 20% is a high-purity sterile plasma protein solution prescribed to restore circulating blood volume and maintain oncotic pressure. Processed and fractionated in strict conformity with European Pharmacopoeia (Ph. Eur.) standards.
Clinical Indications
- Hemodynamic stabilization and volume restoration in acute hypovolemic shock.
- Management of hypoalbuminemia and oncotic pressure regulation.
- Adjunct therapy in therapeutic high-volume plasmapheresis.
- Supportive therapy in severe clinical burns.
Human Immunoglobulin IMMUNOJINE 2500 mg
Immune Globulin Intravenous (IVIG) - 50 ml Injection
Immunojine is a sterile, concentrated Human Normal Immunoglobulin (IVIG) containing active IgG antibodies with optimal subclass distribution. Formulated using advanced phase-purification and nanofiltration to treat immune system disorders.
Clinical Indications
- Replacement therapy in primary and secondary immunodeficiency diseases.
- Immunomodulation in autoimmune disorders and systemic inflammatory conditions.
- Targeted treatment in acute neurological diseases like Myasthenia Gravis.
- Management of severe idiopathic thrombocytopenic purpura (ITP).

Core Values & Mission Statement
Relying on indigenous knowledge, continuous innovation, and compliance with the highest standards of safety and quality in manufacturing biological and pharmaceutical products.
.webp)
Knowledge-Based Innovation
Development of modern biotechnology processes relying on extensive R&D activities and localizing technical knowledge of strategic biological products in Iran.
Self-Sufficiency & National Independence
Reducing import reliance and enhancing national healthcare security through local plasma fractionation, aiming to fulfill the critical needs of patients.
World-Class Quality
Production of all biopharmaceuticals in strict compliance with GMP regulations and WHO quality guidelines to guarantee absolute biosafety for patients.
Have a Question? Find the Answer with
Our Scientific Experts
In this section, we have endeavored to answer your frequently asked questions about the plasma fractionation process, GMP biosafety requirements, and strategic cold chain logistics in the most scientific manner.

Dr. Ali Mousavi
Director of Scientific Support & Biotechnology
Still Have Unanswered Questions?
Didn't find your answer? Our scientific support is ready to guide healthcare centers and esteemed physicians.
